Suppliers Rank Fujifilm “Best in KLAS” for Three Synapse®
Lexington, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — February 8, 2022, Lexington, Mass. – FUJIFILM Healthcare Americas Corporation, a leading provider of imaging and enterprise computing solutions, ranked #1 in KLAS Research’s 2022 “Best in KLAS” report for Synapse VNA and Synapse Cardiology Fujifilm’s PACS in the United States, and Synapse Radiology PACS in Latin America.
Synapse VNA, Cardiology PACS and Radiology PACS are three of Fujifilm’s leading enterprise imaging solutions that enable healthcare organizations to better manage today’s extensive radiology. imaging datasets from cardiology and specialty departments, and improve access to this information in the patient’s electronic health record across the healthcare enterprise.
“We’ve made significant investments in our Synapse Enterprise Imaging product portfolio over the past few years, while at the same time transitioning to a proactive and optimization-focused support approach, and it’s so great to see our customers react that way,” said Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “We are honored to receive the Best in KLAS award for three of our Synapse solutions. We will take this direct customer feedback as confirmation that we are moving in the right direction, and we will continue to listen and collaborate with our valued vendor partners as we strive to further optimize our customer experience.
Synapse VNA: As the core of Fujifilm’s Synapse Enterprise Imaging portfolio, Synapse VNA has now earned the Best in KLAS designation for three consecutive years. VNA seamlessly coordinates multiple patient IDs, populates a centralized patient index, and simplifies the sharing of all enterprise imaging content across PACS, facilities, departments, and teams. Synapse VNA manages more than 40 billion objects from 1,500 facilities across six continents to bring a complete picture of patient health to providers around the world.
Synapse Radiology and Cardiology PACS: Developed under the continued guidance of radiologists and cardiologists, Fujifilm’s Synapse PACS is a robust server-side rendering solution that helps streamline image analysis, interpretation and reporting for radiology and cardiology studies. throughout the company. An industry first, Synapse 7x PACS combines radiology, cardiology and specialty department imaging through a single diagnostic PACS viewer.
KLAS is an independent research organization that monitors and evaluates the performance of health care providers. The “Best in KLAS” designation is reserved for solutions from vendors that dominate the software and services market segments that have the broadest operational and clinical impact on healthcare organizations.
“Each year, thousands of healthcare professionals around the world take the time to share their voice with KLAS. They know that sharing their perspective helps suppliers improve and helps their peers make better decisions,” says Adam Gale, CEO of KLAS. “These conversations are a constant reminder to me of how necessary accurate, honest, and unbiased reporting is in the healthcare industry. The Best in KLAS report and the awards it contains set the standard of excellence for software and computing companies. Suppliers who earn the title of Best in KLAS should celebrate and be reminded that suppliers now only accept the best of their products and services.The Best in KLAS award serves as a signal to supplier and payer organizations that they must expect excellence from the winning suppliers.
Click below to access Fujifilm’s Best in KLAS 2022 report segments for:
Click here to download the full 2022 Best in KLAS report.
Click here to learn more and book your HIMSS 2022 demo today.
FUJIFILM Healthcare Americas Corporation is a leading innovator of diagnostic and enterprise imaging solutions designed to meet changing healthcare needs for prevention, diagnosis and treatment. Fujifilm’s medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy and endosurgery. The Synapse® Enterprise Imaging portfolio provides healthcare professionals with access to the imaging and data needed to provide a complete patient record. REiLI®, Fujifilm’s artificial intelligence initiative, combines Fujifilm’s rich image processing heritage with cutting-edge AI innovations to inspire a new level of clinical confidence. The in vitro diagnostics portfolio provides the gold standard of molecular immunoassay technology for liver monitoring, advanced clinical diagnostic chemicals for leading laboratories nationwide, and diagnostic chemicals for OEM white labeling. The company is headquartered in Lexington, Massachusetts. For more information, visit healthcaresolutions-us.fujifilm.com
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting-edge solutions to a wide range of global industries by leveraging its deep knowledge and core technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields, including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the fiscal year ended March 31, 2021, the company had worldwide revenue of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, visit: www.fujifilmholdings.com
KLAS is a data-driven company on a mission to improve healthcare around the world by enabling the voices of providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS collects information about medical software, services and equipment to provide reports, trend data and statistical insights. KLAS data is accurate, honest and unbiased. Research directly reflects the voice of healthcare professionals and acts as a catalyst to improve provider performance.
To learn more about KLAS and the information we provide, visit KLASresearch.com